cagrilintide trial Efficacy and safety of co-administered once-weekly 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 New in the August 14,

Preclinical and early exploratory research has used ARA-290 to investigate innate-repair receptor engagement in models relevant to small-fiber damage associated with systemic inflammatory conditions

For use only by healthcare professionals trained in injection techniques

This cutting-edge treatment is transforming the approach to weight loss and fat reduction, offering new hope for those struggling with stubborn fat deposits

If your B12 level is low, restoring it may improve your energy, mood and overall wellbeing

These tools help determine how much solvent to add and how much solution to draw for a specific amount